CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News:

AFYREN (Paris:ALAFY), a greentech company that offers manufacturers bio-based, low-carbon products through its unique fermentation technology based on a completely circular model, announces today its financial calendar for 2023

Indicative financial calendar¹

Events	Dates
2022 Full-Year Results	Tuesday March 21, 2023
Annual General Meeting	Wednesday, June 21, 2023
2023 Half-Year Results	Monday October 2, 2023

About AFYREN

Founded in 2012 to meet the growing need of industries to reduce the use of petroleum derivatives in their production chain, AFYREN produces biomolecules derived from the reuse of non-food biomass. These molecules have the exact same properties as petro-sourced molecules and are largely used in the human and animal nutrition, cosmetics, flavors and fragrances and fine chemicals sectors.

By offering natural alternatives to these strategic markets, AFYREN is engaged in a low-carbon economy and proposes a truly circular approach with the use of local biomass and the choice of a strategic location, as close as possible to its customers.

Resulting from 10 years of research, AFYREN’s disruptive innovation won the 2030 Global Innovation Contest in the “Plant proteins and plant chemistry” category and was selected in the French Tech 120 in 2020 and 2021. In 2018, AFYREN committed to its industrial project by creating the AFYREN NEOXY joint venture with Bpifrance’s SPI fund. AFYREN NEOXY is dedicated to the first industrial production of AFYREN natural organic acids in the Grand Est region. In 2022, the AFYREN NEOXY plant was inaugurated. AFYREN and AFYREN NEOXY now employ nearly 100 people at their sites in Lyon, Clermont-Ferrand and Carling Saint-Avold. In 2021, AFYREN listed on Euronext Growth^® exchange in Paris with the objective of accelerating its industrial development (ISIN code: FR0014005AC9, ticker: ALAFY).

For more information: afyren.com

¹Information subject to change.

Contacts

Investor relations
Mark Reinhard

[email protected]

Investor Relations
NewCap
Théo Martin / Mathilde Bohin

Tel: +33 1 44 71 94 94

[email protected]

Press relations
Bogert-Magnier Communications

James Connell

Tel: +33 6 2152 1755

[email protected]